{"id":10070,"date":"2022-09-06T19:19:08","date_gmt":"2022-09-06T13:49:08","guid":{"rendered":"https:\/\/www.tickertape.in\/blog\/?p=10070"},"modified":"2022-09-06T19:39:50","modified_gmt":"2022-09-06T14:09:50","slug":"aarti-drugs-the-counter-may-soon-have-an-extra-energy-drug","status":"publish","type":"post","link":"https:\/\/www.tickertape.in\/blog\/aarti-drugs-the-counter-may-soon-have-an-extra-energy-drug\/","title":{"rendered":"Aarti Drugs: The Counter May Soon Have an Extra Energy Drug!"},"content":{"rendered":"\n

This article is authored by Kunal Rambhia, a fund manager at The Streets, a private fund. He has been in the equity<\/a> market since 2010, in various roles such as Associate Research Analyst, Research Analyst, and Associate Portfolio Manager<\/a>. He has media appearances with CNBC and ET NOW and is a visiting faculty in multiple colleges.<\/em><\/p>\n\n\n\n

Markets have turned stock specifics. Extra strength is witnessed on indices, and counters have done good so far. Till we get further clarity, I would prefer to go stock specifics where the risk-reward is favourable, and bargain bets are available. One of such counters is Aarti Drugs<\/a>. Let\u2019s go through all observations. <\/p>\n\n\n\n

\n
\n

Table of Contents<\/p>\n<\/span><\/div>\n